Clarkston Capital Partners LLC Sells 87,940 Shares of Avantor, Inc. (NYSE:AVTR)

Clarkston Capital Partners LLC lowered its stake in shares of Avantor, Inc. (NYSE:AVTR) by 1.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,672,430 shares of the company’s stock after selling 87,940 shares during the quarter. Avantor accounts for 2.7% of Clarkston Capital Partners LLC’s investment portfolio, making the stock its 15th largest holding. Clarkston Capital Partners LLC’s holdings in Avantor were worth $146,746,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also bought and sold shares of the company. Versant Capital Management Inc boosted its stake in shares of Avantor by 2,003.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after buying an additional 1,102 shares during the last quarter. Blue Trust Inc. boosted its position in Avantor by 1,830.3% in the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after purchasing an additional 1,391 shares during the last quarter. UMB Bank n.a. purchased a new position in Avantor in the third quarter worth $49,000. Nisa Investment Advisors LLC grew its stake in Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after purchasing an additional 835 shares during the period. Finally, GAMMA Investing LLC increased its position in shares of Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after purchasing an additional 1,285 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.50% of the company’s stock.

Avantor Price Performance

Shares of NYSE:AVTR opened at $20.74 on Monday. Avantor, Inc. has a 12 month low of $19.11 and a 12 month high of $28.00. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The stock has a market cap of $14.12 billion, a P/E ratio of 45.09, a P/E/G ratio of 2.51 and a beta of 1.35. The company has a 50 day moving average of $24.52 and a 200 day moving average of $24.00.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Morgan Stanley lifted their price objective on shares of Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Stifel Nicolaus upped their price objective on Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Barclays decreased their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Finally, Robert W. Baird decreased their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Avantor has a consensus rating of “Moderate Buy” and a consensus price target of $27.57.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.